Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Second Allox phase I/II trial completed

Oct. 30, 2002

Pilot study of the humanized anti-C5 monoclonal antibody eculizumab in dermatomyositis

Oct. 29, 2002

New C5a and/or IL-8 antagonists identified by Dompe researchers

Oct. 24, 2002

GSK describes new IL-8 antagonists and their use in psoriasis, arthritis, etc.

Oct. 24, 2002

Potential use of two novel PDE4 inhibitors in allergic dermatitis

Oct. 24, 2002

Alefacept reported to be a valid therapeutic option for chronic psoriasis

Oct. 21, 2002

New data on the safety and efficacy of topical tacrolimus in atopic dermatitis

Oct. 21, 2002

Scientists at Ajinomoto synthesize inhibitors of activation of inflammatory factors

Oct. 21, 2002

Topical liposomal tacrolimus effective in murine model of immune-mediated skin disorders

Oct. 18, 2002

Unexpected efficacy reported for topiramate in psoriasis

Oct. 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...